BC
Brandon Christopher Smith
About Brandon Christopher Smith
Data last updated:
Brandon Christopher Smith is a Director at Molecular Products Group India Private Limited (since 2023). The company operates in Travel and Hospitality. Molecular Products Group India Private Limited reported revenue of ₹86.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Molecular Products Group India Private Limited U74120MH2016FTC271967 | Director | 26 May 2023 | 2016 | ₹86.3 Lakh (FY 2025) | Active |
Board colleagues of Brandon Christopher Smith
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jan Willem Radstaak | 07288946 | Molecular Products Group India Private Limited | Director |
| Kelly Anne Reinke | 10178751 | Molecular Products Group India Private Limited | Director |
| Vikrant Bapusaheb Patil | 01125572 | Molecular Products Group India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brandon Christopher Smith
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brandon Christopher Smith
Brandon Christopher Smith currently holds 1 directorship: Molecular Products Group India Private Limited (Director, since 26 May 2023, revenue ₹86.3 Lakh (FY 2025)).
Brandon Christopher Smith was first appointed on 26 May 2023 as Director at Molecular Products Group India Private Limited.
The current boards of Brandon Christopher Smith's companies include Jan Willem Radstaak (Molecular Products Group India Private Limited), Kelly Anne Reinke (Molecular Products Group India Private Limited), Vikrant Bapusaheb Patil (Molecular Products Group India Private Limited).